Lido Advisors, LLC Novo Nordisk A S Transaction History

Lido Advisors, LLC

$21.7 Billion
Q4 2024

A detailed history of Lido Advisors, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lido Advisors, LLC holds 100 shares of NVO stock, worth $8,340. This represents 0.0% of its overall portfolio holdings.

Number of Shares

100

Previous 2,000 95.0%

Holding current value

$8,340

Previous $238,000 96.64%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$85.0 - $120.04 $55,590 - $78,506	654 Added 0.38%	173,403 $14.9 Million
Q3 2024 Nov 14, 2024	BUY	$119.07 - $145.42 $2.51 Million - $3.07 Million	21,087 Added 13.9%	172,749 $20.6 Million
Q2 2024 Aug 14, 2024	BUY	$122.71 - $146.91 $642,509 - $769,220	5,236 Added 3.58%	151,662 $21.6 Million
Q1 2024 May 15, 2024	BUY	$102.11 - $135.92 $1.13 Million - $1.51 Million	11,076 Added 8.18%	146,426 $18.8 Million
Q4 2023 Feb 14, 2024	BUY	$87.78 - $105.45 $920,812 - $1.11 Million	10,490 Added 8.4%	135,350 $14 Million
Q3 2023 Nov 14, 2023	BUY	$90.94 - $199.54 $5.94 Million - $13 Million	65,337 Added 109.77%	124,860 $11.4 Million
Q2 2023 Aug 09, 2023	BUY	$155.98 - $172.65 $8.19 Million - $9.07 Million	52,534 Added 751.67%	59,523 $9.63 Million
Q1 2023 May 15, 2023	BUY	$132.34 - $159.14 $303,190 - $364,589	2,291 Added 48.77%	6,989 $1.11 Million
Q4 2022 Feb 14, 2023	BUY	$102.55 - $135.33 $83,373 - $110,023	813 Added 20.93%	4,698 $635,000
Q3 2022 Nov 14, 2022	BUY	$95.28 - $116.93 $28,869 - $35,429	303 Added 8.46%	3,885 $387,000
Q2 2022 Aug 15, 2022	BUY	$103.24 - $121.81 $70,925 - $83,683	687 Added 23.73%	3,582 $399,000
Q1 2022 May 17, 2022	BUY	$93.1 - $112.54 $48,132 - $58,183	517 Added 21.74%	2,895 $321,000
Q4 2021 Feb 15, 2022	BUY	$95.88 - $117.08 $228,002 - $278,416	2,378 New	2,378 $266,000

Others Institutions Holding NVO

# of Institutions

1,876

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $188B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.

Account

Lido Advisors, LLC Novo Nordisk A S Transaction History